← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2015Last known activity
Dec 16, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 7 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT04854486Reponsible party - principal investigatorPhase 3Dec 16, 2021
- NCT04854486Lead sponsorPhase 3Dec 16, 2021
- NCT04858620Lead sponsorPhase 3Aug 30, 2020
- NCT04858620Reponsible party - principal investigatorPhase 3Aug 30, 2020
- NCT04610801Lead sponsorPhase 3Aug 8, 2020
- NCT04610801Overall official - principal investigatorPhase 3Aug 8, 2020
- NCT04610801Reponsible party - principal investigatorPhase 3Aug 8, 2020
- NCT06084351Lead sponsorPhase 3May 12, 2020
- NCT04790487Sponsor investigatorPhase 2/Phase 3Jul 30, 2019
- NCT04790487Lead sponsorPhase 2/Phase 3Jul 30, 2019
- NCT02586727Lead sponsorPhase 2Oct 1, 2015
- NCT02416128Lead sponsorPhase 2Apr 1, 2015
Details
- Last known activity
- Dec 16, 2021